GANX
Gain Therapeutics Inc
1.80$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -90.6% | +10,375.8% | +78.2% | -93.7% | -92.3% | +10,333.7% | +22.5% | -99.2% | -21,462.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -100.4% | – | – | |
| – | +0.3% | +5.6% | +77.0% | -40.9% | -53.3% | +84.3% | +22.2% | +3.3% | -17.6% | +17.7% | -22.6% | – | |
| – | -19.2% | -8.0% | +100.2% | -50.9% | +14.6% | +0.3% | +10.3% | -16.9% | +9.4% | +22.3% | -1.8% | – | |
| – | -9.8% | -0.7% | +86.9% | -45.5% | -25.3% | +31.2% | +16.5% | -6.0% | -6.7% | +19.9% | -12.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -32.4% | +37.0% | -93.9% | +809.3% | +4,491.0% | -80.1% | +40.5% | +289.0% | -87.2% | +161.1% | -43.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.